ESC Premium Access

Everything you need to know about SGLT2 inhibitors in heart failure

Event: ESC Congress 2021 - The Digital Experience
Topic: Chronic Heart Failure
Session type: Symposium
Date: 30 August 2021
Time: 08:00 - 08:45

Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

Who should be treated with an SGLT2 inhibitor?

Speaker: Professor J. McMurray (Glasgow, GB)
Thumbnail

SGLT2 inhibitors in heart failure: do I have to worry about the kidneys?

Speaker: Doctor K. Damman (Groningen, NL)
Thumbnail

SGLT2 inhibitors in heart failure: adjusting other treatments and what to tell the patient.

Speaker: Professor A. Cahn (Jerusalem, IL)
Thumbnail

Everything you need to know about SGLT2 inhibitors in heart failure – discussion.

Thumbnail

3 speakers from this session

Professor John J V McMurray

Western Infirmary, Glasgow (United Kingdom of Great Britain & Northern Ireland)
82 presentations
2 followers

Doctor Kevin Damman

University Medical Center Groningen, Groningen (Netherlands (The))
10 presentations
1 follower

Professor Avivit Cahn

Hadassah - Hebrew University Medical Center Jerusalem, Jerusalem (Israel)
2 presentations
0 follower

Related content

ESC Premium Access

Evolving role of SGLT2i in HFrEF management

3 December 2021

ESC Premium Access

Update on endocarditis in 2021

3 December 2021

ESC Premium Access

Pregnancy in women with cardiovascular disease

3 December 2021

This platform is supported by

logo Novo Nordisk